OXER1 and Anxiety: More importantly, OX levels were elevated in the cerebrospinal fluid of human subjects with panic compared to controls [16], a selective orexin-1 receptor antagonist reduced CO2-induced fear and anxiety symptoms [18], and the dual OX receptor antagonist suvorexant improved anxiety symptoms in insomnia patients in a recent clinical trial [19].